CHICAGO (GenomeWeb) – A longstanding collaboration between bioinformatics firm Berg and the US Department of Defense is getting ready to bear fruit.

Berg is, according to Senior Vice President and Chief Analytics Officer Slava Akmaev, in the "final stages" of commercializing a diagnostic test for prostate cancer, in conjunction with the DoD Uniformed Services University's Center for Prostate Disease Research.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.